 Fmr LLC grew its position in shares of Eidos Therapeutics Inc NASDAQ:EIDX by 10.8 in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities Exchange Commission. The fund owned 411,247 shares of the companys stock after purchasing an additional 40,000 shares during the period. Fmr LLC ... 